The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)
Official Title: REPLICA: Real Patient Life Treatment With Cabozantinib in Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic RCC: a Descriptive and Prospective Non Interventional Study.
Study ID: NCT04106349
Brief Summary: The purpose of this study is to describe the real-life use of Cabometyx® in monotherapy or in combination with nivolumab in Belgium in patients with advanced or metastatic Renal Cell Carcinoma (1st, 2nd and later lines of treatment)
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Onze-Lieve-vrouw Ziekenhuis Aalst, Aalst, , Belgium
Vivalia Hôpital d'Arlon, Arlon, , Belgium
Imeldaziekenhuis, Bonheiden, , Belgium
Clinique Saint-Luc Bouge, Bouge, , Belgium
AZ Sint-Jan Brugge, Brugge, , Belgium
AZ Sint-Lucas, Brugge, , Belgium
Hôpital Erasme, Brussels, , Belgium
UZ Brussel, Brussels, , Belgium
Chirec Delta, Brussels, , Belgium
Ziekenhuis Oost-Limburg Genk, Genk, , Belgium
Universitair Ziekenhuis Gent, Gent, , Belgium
Virga Jessa Ziekenhuis, Hasselt, , Belgium
Hôpital de Jolimont, La Louvière, , Belgium
CHC MontLegia, Liège, , Belgium
CHR Citadelle Liège, Liège, , Belgium
CHU Liège / Sart-Tilman, Liège, , Belgium
Hôpital Ambroise-Paré Mons, Mons, , Belgium
CHU Charleroi - site André Vésale, Montigny-le-Tilleul, , Belgium
Clinique Saint-Pierre, Ottignies, , Belgium
AZ Delta, Roeselare, , Belgium
AZ Glorieux, Ronse, , Belgium
CHWAPI, Tournai, , Belgium
AZ Turnhout, Turnhout, , Belgium
CHR Verviers, Verviers, , Belgium
UCL Namur - site Godinne, Yvoir, , Belgium
Name: Ipsen Medical Director
Affiliation: Ipsen
Role: STUDY_DIRECTOR